Welcome to PakSearch.com Pakistan's Premier Business Information
Service


For business information, annual reports, laws, ordinances, regulations and articles.




Google
 
Web Paksearch.com
ICI Pakistan Limited 
(Annual Report 1996)
Company Information
Board of Directors: The Executive Committee:
Naseem S Mirza Munnawar Hamid
(Chairman) Chief Executive
Munnawar Hamid
(Chief Executive) Mahmood Saeed
Irtiza Husain Executive Director
M J Jaffer
Razi-ur-Rahman Khan Azhar A. Malik
I M Macfarlane Executive Director
(Alternate: Javed H Malik)
Azhar A Malik
Mahmood Saeed
General Managers:
Imran Agha
Ijaz Ahmad
Sheikh M Aslam
J S Butt
Javed H Malik
Waqar A Malik
John D Mehta
Jehangir B Nawaz
Khalid B Osmany
Rashiq Sufi
Company Secretary:
Sheikh M Aslam
Bankers:
ABC International Bank Plc
ABN-AMRO Bank NV
A1 Faysal Investment Bank Limited
Allied Bank of Pakistan Limited
American Express Bank Limited
ANZ Grindlays Bank Lid
Australia & New Zealand Banking Group Limited
Bank of America NT&SA
Banque Indosuez
Citibank NA
Deutsche Bank
Emirates Bank International PJSC
Faysal Bank Limited
Habib Bank Limited
Habib Credit & Exchange Bank Limited
Habib Bank AG Zurich
HongKong & Shanghai Banking Corporation Limited
Muslim Commercial Bank Limited
MashreqBank psc
Midland Bank plc
National Bank of Pakistan
National Westminster Bank PLC
Pakistan Kuwait Investment Company (Private) Limited
Societe Generale, The French and International Bank
Standard Chartered Bank
The Bank of Tokyo-Mitsubishi Limited
United Bank Limited
Auditors: 
A F Ferguson & Co
Registered Office:
ICI House, 5 West Wharf, Karachi 74000
Statistical Data
Year at a Glance
Rs Million
1996 1995
Turnover 8,152 7,013
Profit before taxation 814 888
Taxation
Current 134 295
Deferred 138 4
Profit after taxation 542 589
Dividend 325 290
Gross assets employed (excluding capital work-in-progress) 7,834 5,455
Paid-up capital 1,856 580
Shareholders' equity 9,304 3,067
Earnings per share after taxation - Rupees 2.92 10.17
Number of employees 1,835 1,873
Report of the Directors for the Year Ended 31 December 1996
The Directors take pleasure in presenting
their Report together with the audited
accounts of the Company for the year ended
31 December 1996.
Board of Directors
Mr Naseem S Mirza will relinquish office as
Chairman/Director at the conclusion of the
Annual General Meeting to be held on
17 April 1997 after 38 years of association
with the Company. He became a Director
of the Company in 1973 and was
Chairman & Chief Executive for 12 years
and Chairman for over a year and a half.
The Board has approved the
appointment of Mr Desmond O'Shea as
Chairman/Director in place of Mr Naseem
S Mirza. Mr Desmond O'Shea is the
Regional Executive - Asia, Imperial
Chemical Industries PLC, and is based
in London.
Dr lain M Macfarlane, Group Manager-
Regional Business, Imperial Chemical
Industries PLC, who has been on the Board
of ICI Pakistan Limited since September
1993 will also relinquish office after the
Annual General Meeting on 17 April 1997
on his appointment as Regional Executive -
Western Hemisphere.
Subject to approval by the shareholders,
it is proposed to increase the number of
elected Directors of the Company from eight
to nine and to elect Mr Rashiq Sufi, who has
been with the Company for over fifteen
years and has broad based experience of its
operations, against the additional position.
The Board places on record its
appreciation of the valuable services
rendered by Mr Naseem S Mirza and
Dr lain M Macfarlane and extends a warm
welcome to Mr Desmond O'Shea and
Mr Rashiq Sufi.
Overview
During 1996 the Government once again made numerous
fiscal changes to meet IMF conditionalities. Rising taxes
and levies together with falling tariffs on finished goods
imports restricted selling prices and margins for
domestically manufactured products. To check monetary
expansion and lower the fiscal deficit to meet targets
agreed with the IMF, interest rates increased to an all time
high. All these combined to create difficult trading
conditions in general and for some businesses in
particular.
Your Directors are pleased to report that despite these
problems the Company performed well during the year. All
businesses showed strong volume growth, and supported
by essential restructuring throughout the Company were
able to control costs and improve productivity. As a
consequence all businesses performed excellently and
achieved record profits, except Polyester Fibre and
Pharmaceuticals where margins came under
unprecedented external pressure and caused a very
significant adverse swing of Rs 476 million in operating
profit compared to 1995. However the exceptional
performance of the other businesses almost totally made
up for it and overall operating profit at Rs 975.5 million in
1996 was very near to previous year's. In addition, total
turnover exceeded Rs 8 billion, a 16% improvement over
last year.
The Company's polyester staple fibre expansion has
been successfully commissioned and commercial
production commenced in February 1997. Progress on the
US$ 450 million PTA project is proceeding on the 'fast
track' as planned and is expected to be commissioned by
the end of the year.
The Board wishes to express its deepest appreciation
for the hard work and efforts put in by staff at all levels and
the co-operation and support of all its customers,
distributors and dealers in achieving these results during a
year of unprecedented difficulties.
A detailed review follows:
Polyester
The plant operated at full capacity with
production during the year remaining at
about last year's level, but continued
buoyancy in domestic demand resulted in
sales volume being 18% higher. However,
selling prices remained under pressure
throughout the year as a result of
unprecedented low prices quoted by
exporters from the Far East and Saudi
Arabia, for whom Pakistan remains a
marginal market.
With raw material prices slow in
adjusting to lower polyester staple fibre
prices, quite unlike the traditional trend,
out for the better part of the year. As raw
material prices fully adjusted to the low
fibre prices and the November devaluation
brought relief for local selling prices,
profitability returned to the Business but too
late in the year, and consequently the
Business recorded an operating loss of
Rs 31.8 million in 1996.
The issue of dumping continues to
threaten the local polyester staple fibre
industry and has now assumed greater
significance as import duties fall in line with
IMF conditionalities. Your Company has
lobbied very strongly for effective anti-
dumping legislation and has been assured
of appropriate Government action.
Work on the Expansion project was
completed in December 1996, and after
successful commissioning earlier this year
it is now in commercial production giving
the Sheikhupura plant an expanded total
polymerisation capacity of over 91,000
tonnes per annum and a fibre capacity of
about 60,000 tonnes per annum.
Soda Ash
The industrial relations situation at
Khewra normalised in February 1996 and a
two yearly wage agreement was signed
with the Union. Plant operations as a
consequence normalised and production
as well as productivity and efficiencies
improved substantially leading to record
production of 190,235 tonnes against
165,698 tonnes last year despite severe
gas curtailment in the first quarter.
Whereas business conditions in the
glass sector remained subdued owing to
excess capacity and sluggish demand from
the beverage industry, and the silicate
market showed marginal growth amidst
increased competition, the overall Soda
Ash market showed strong growth driven
by the paper and detergent segments.
Record production during the year enabled
the Business to almost fully support this
growth, albeit owing to low production in
1995 there was still need to supplement it
with imports of 3,000 tonnes during the first
quarter of 1996 to fully service customer
needs. As a result, turnover increased by
38% compared to last year. A price
increase of 10% in December 1996
allowed partial recovery of the significant
increase in input costs, particularly in gas
and electricity. However, higher production
and improved conversion efficiencies
enabled operating profit to increase by
86% compared with last year.
Sales of Sodium Bicarbonate also grew
significantly over 1995 with ICI gaining a
stronghold in the market. Calcium
Carbonate has achieved market
acceptance and further increase in
production in line with demand is expected.
Paints
Weak market conditions prevailed
throughout the year as a result of political
and economic uncertainty. The Motors
segment continued to face weak trading
conditions which, compounded by
increased taxation, led to lower car sales
and forced automobile manufacturers to
curtail production. The tractor, motorcycle
and cycle industries also came to a virtual
standstill for similar reasons. Nevertheless,
it was possible in the case of Decorative
products to not only consolidate market
positions but also to increase share
through strong brand marketing, and in the
case of Refinish paints to increase volumes
significantly as a result of strong demand
for the high quality 2-pack system
introduced last year. Consequently, despite
an overall marginal growth in the national
paints market, the Paints Business
achieved a record 27% growth in turnover
over 1995.
Although Rupee devaluation and
firming up of chemical prices in the last
quarter brought margins under pressure,
stable raw material costs prevailed for the
better part of the year which together with a
strict control on fixed costs and improved
production efficiencies enabled the
Business to increase its margins.
Combined with higher Decorative and
Refinish volumes this has resulted in
operating profit for the year to be higher by
51% compared with last year.
Sales tax on the organised sector of the
industry was increased by another 3% in
the year, bringing the total excise duty and
sales tax charge to 28%. This together with
fixed capacity tax on the unorganised
sector, though briefly removed during the
year but reinstated, continued to place the
latter at a very unfair advantage versus the
organised sector. Your Company continues
to lobby for a reduction in this taxation
burden and the removal of capacity tax
which should not only produce level playing
fields but also increase Government
revenue from the unorganised sector.
Agrochemicals
and Seeds
Your Company's Agrochemicals Business
was singularly successful in achieving a
major strategic objective during the year
which was to expand its product portfolio.
Four new herbicides, one in rice and three
in cotton were established in the market by
the Business, which has significantly
broadened its product base and
appropriately reduced over-dependence on
cotton insecticides. During the 1996 cotton
season, late and sporadic rainfall
accompanied by high temperatures
resulted in low boll-worm infestation levels,
which had an unfavourable impact on
overall market size and adversely affected
sales of 'Karate'. However, this was more
than compensated by the new products of
the expanded portfolio and compared with
last year, the Business registered an
improvement of 47% in sales volume and
16% in turnover. With this growth and an
increase in occupacity of its formulation
plant, through expanded toll manufacturing
and packaging services for other suppliers,
the Business recorded a significantly
higher operating profit as well.
The Seeds' Business once again had
an exceptional year compared with last
year as turnover and sales volume were up
by 101% and 53% respectively, leading to
a significant increase in operating profit.
The Business maintained its lead position
in the sunflower and fodder hybrid markets
and was also the first to successfully test
market hybrid Canola seed, Hyola 42, to
which initial response has been
encouraging.
Pharmaceuticals
The Pharmaceuticals Business increased
its turnover by 15% over last year. Margins,
however, came under severe pressure due
to a combination of repeated Rupee
devaluations, imposition of import duty and
a levy of non-adjustable sales tax on
imported raw material. Although the
Government allowed a price increase of
6% towards the end of the year, it was
insufficient to offset the significantly high
increase in input costs.
The Medical segment of the Business
continued to strengthen its market position
showing a healthy sales growth over last
year with cardiovascular products once
again taking the lead. 'Merenem', an
injectable antibiotic, was successfully
launched during the latter half of the year
along with the 'Alphosyl' range of products
for skin treatment. Performance of the
anaesthetic, antiseptic and NSAIDS ranges
was steady with continued good market
acceptance.
The Animal Health segment continued
to show volume growth compared with last
year despite strong competition from
cheaper generic products. Sales of
anthelmentics were steady and the newly
introduced poultry products range achieved
initial market penetration.
Chemicals
The Chemicals Business demonstrated
record growth in profitability over last year
as turnover and sales volume increased by
36% and 22% respectively. Turnover in
Specialty Chemicals was considerably
higher than last year mainly because of
higher sales in the Paint Lattices and
Textile Auxiliaries segments. In General
Chemicals, turnover was also significantly
higher than 1995 primarily due to higher
sales of titanium dioxide and nickel
catalyst. Introduction of the NALCO range
of water treatment chemicals and a strong
demand for polyurethanes by the domestic
appliances and footwear sectors also
helped to increase turnover.
Pure Terephthalic
Acid (PTA)
Progress on the US $ 450 million plant to
manufacture Pure Terephthalic Acid at
Port Qasim is proceeding according to a
fast track' plan. Detailed engineering
design is complete and equipment
ordering and shipments are nearing
completion. Civil works are almost
complete and steel work erection and
installation of pipework are at an
advanced stage of progress.
All long-term agreements for
infrastructural support including raw
materials handling, supply of raw water
and industrial gases, power from KESC
and natural gas from SSGC are in place,
and construction activities for making
these services available are progressing
as scheduled.
Recruitment activity is significantly
complete and selected technical staff
have already received training in the UK in
preparation for plant commissioning
activities, which are expected to be
complete by end 1997. Commercial
negotiations with customers are in hand
and a market seeding programme with
imported ICI product will be implemented
during the year, ahead of the
commencement of local commercial
production expected from January, 1998
onwards.
Strong Government support continues
for this investment as a whole as well as
for Project construction on the ground
which has enabled progress on the 'fast
track'.
Profit, Finance
and Taxation
Operating profit for 1996 at Rs 975.5 million was
marginally below 1995. An interim dividend of 17.5%
was paid in September and as already explained in the
half-yearly Directors' report, it was not considered
appropriate that the capital from the rights which was
received in December 1996 should rank for dividend in
1996 and accordingly the Directors do not recommend a
final dividend for 1996.
The Profit and Loss appropriations for the year are as follows:
The net profit of the Company for the year before providing for Rs'000
taxation but after provision has been made for depreciation is: 814,457
Less: provision for taxation
Current 134,071
Deferred 138,369
----------
272,440
----------
Profit after taxation 542,017
Unappropriated profit brought forward 190,008
----------
Profit available for appropriation 732,025
Appropriations
Interim dividend @ Rs 1.75 per share 324,738
Transfer to General Reserve 200,000 524,738
----------
Unappropriated profit carried forward 207,287
==========
Local currency debt funding arrangements for the PTA
project are proceeding satisfactorily as planned,
ABN-AMRO Bank was given a mandate to raise
Rs 1 billion which was accomplished by a 3-year term loan
of Rs 325 million from Pakistan Kuwait Investment
Company (Private) Limited and a Rs 675 million term loan
arranged through a syndicate of banks. In addition, your
Company issued Term Finance Certificates of
Rs 1 billion in September 1996 which was by far the
largest issue in the Pakistan stock market, and it gives
your Directors great pleasure to inform you that The
Pakistan Credit Rating Agency rated the issue "AA", the
highest given to any private sector company. The issue
was oversubscribed one and a half times which is a further
confirmation of investor confidence in your Company.
Approximately two-thirds of the local currency funding is
now complete and the remaining will be obtained during
1997, arrangements for which are in hand.
In order to raise equity capital for part financing the
PTA project, right shares at par were issued in the ratio
of 13 new shares for every four shares held, following a
Special Resolution approved in the last AGM increasing
the authorised share capital to Rs 10 billion.